| Literature DB >> 32269910 |
Dimitrios Z Panagiotou1,2, Angeliki A Chranioti1,3, Sofia-Eleni Tzorakoleftheraki4, Nikolaos G Ziakas1, Panagiotis K Oikonomidis1.
Abstract
Purpose: To present an extremely rare case of corneal melanoma. Method: An 84-year-old female patient presented to our department with a pigmented corneal lesion in her right eye (OD), 6x4 mm, complaining of mild pain and inability of complete eyelid closure. Tumor growth had been noted the previous year. She had undergone cataract surgery in her right eye three years before, followed by an unspecified postoperative complication. Her visual acuity was 3/10 OD and 9/10 OS. Ophthalmic evaluation and ultrasonography (A- and B-scan) did not reveal any other pathology. The pigmented lesion was surgically removed and the patient underwent a protocol therapy of topical chemotherapy (mitomycin 0.03%, 2x4 for 2 weeks and dexamethasone 0.1%, 2x4 for the following 2 weeks, followed by another cycle of mitomycin 0.03%, 2x4 for another 2 weeks).Entities:
Keywords: cornea; corneal melanoma; topical chemotherapy
Year: 2020 PMID: 32269910 PMCID: PMC7114650 DOI: 10.3205/oc000139
Source DB: PubMed Journal: GMS Ophthalmol Cases ISSN: 2193-1496
Figure 1Primary melanoma of the cornea; A), B) and C) corneal pigmented lesion, clearly demarcated and surrounded by clear cornea, with two feeder vessels derived from the limbus; D) inability of complete eyelid closure
Figure 2Imaging which did not reveal associated pathology; A), B), C) and D) A- and B-scan; E) and F) UBM – lesion sparing posterior stroma and endothelium; (courtesy of Dr. Miltos Balidis, OPTHALMICA Eye Institute)
Figure 3AS-OCT; A) preoperative; B) post-operative
Figure 4Photographs taken post-operatively; A) and B) day 1; C) and D) week 6; E), F) and G) week 8
Figure 5Histologic features; A) low-power view of the neoplasm, hematoxylin-eosin, x100; B) high-power view illustrating the cytologic features of the tumor cells, hematoxylin-eosin, x400; C) positive immunostaining of the tumor cells for Melan-A antigen, automated immunohistochemistry, x400; (courtesy of Prof. Prodromos Chitiroglou, Pathology Department, Aristotle University of Thessaloniki, Greece)